Physiologically Based Pharmacokinetics
Physiologically Based Pharmacokinetics (PBPK) · Also known as: PBPK, PBPK modeling
PBPK is a mechanistic modeling framework that uses physiological parameters, tissue properties, and drug-specific attributes to predict drug concentration time profiles in the body. Developed rigorously in the 1990s by researchers including Nestorov, PBPK integrates anatomy, biochemistry, and kinetics to enable rational drug development, bridging in vitro data to clinical outcomes.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use PBPK for novel drugs with complex pharmacokinetics, to predict behavior in special populations (pediatric, elderly, hepatic/renal impairment), and to evaluate drug-drug interactions without extensive clinical trials. It is also valuable for regulatory justification of dose adjustments and formulation decisions.
Strengths & limitations
- Mechanistic foundation enables prediction beyond observed data (e.g., dose extrapolation, population shifts, DDI scenarios)
- Incorporates physiological reality, making it more trustworthy for complex scenarios than empirical compartmental models
- Reduces need for clinical PK studies in special populations by extrapolating from standard population using physiological parameters
- Supports regulatory submissions (FDA, EMA) for complex drug interactions and special populations
- Requires extensive and accurate input data on drug properties and physiology; uncertainty in inputs propagates to predictions
- Parameter optimization is computationally intensive and may not converge to unique solutions
- Model complexity can obscure mechanistic understanding if parameters are poorly characterized or redundant
- Not suitable for non-linear or saturable processes with insufficient mechanistic detail
Frequently asked
How is PBPK different from traditional compartmental PK modeling?
Traditional PK uses empirical compartments (central, peripheral) fitted to data without mechanistic interpretation. PBPK explicitly represents physiological structures (liver, kidney, adipose) and uses drug properties to predict behavior. This makes PBPK more mechanistic and generalizable to new scenarios.
What in vitro data do I need to build a PBPK model?
Essential data include plasma protein binding, metabolic clearance (hepatic and renal), partition coefficients (oil-water), transporter kinetics, and stability. These are typically obtained from assays with human liver microsomes, recombinant enzymes, and cell lines.
Can PBPK predict drug interactions?
Yes, by mechanistically modeling how one drug inhibits or induces metabolizing enzymes or transporters of another drug. This is more predictive than empirical methods and reduces need for clinical DDI studies.
How are physiological parameters validated?
PBPK relies on published organ volumes, blood flows, and enzyme expression levels from textbooks and databases. For a new PBPK model, parameters are compared to literature values and adjusted within physiologically plausible ranges during model refinement.
Sources
- Nestorov, I. (1997). Sensitivity analysis of pharmacokinetic and pharmacodynamic systems. Journal of Pharmacokinetics and Biopharmaceutics, 25(4), 529-543. link ↗
- Reddy, M. B., Yang, R. S., Clewell, H. J., & Andersen, M. E. (2005). Physiologically based pharmacokinetic modeling: science and applications. Hoboken, NJ: John Wiley & Sons. link ↗
How to cite this page
ScholarGate. (2026, June 3). Physiologically Based Pharmacokinetics (PBPK). ScholarGate. https://scholargate.app/en/pharmacology/physiologically-based-pharmacokinetics
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- In Vitro-In Vivo CorrelationPharmacology↔ compare
- Michaelis-Menten KineticsPharmacology↔ compare
- Population PharmacodynamicsPharmacology↔ compare